You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds

Moderna’s COVID-19 vaccine has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for use in adolescents aged 12 to 17 years of age.